A study in Swedish men finds that increasing cardiorespiratory fitness (CRF) over time is associated with a lower risk of prostate cancer incidence, highlighting the potential protective effects of improved fitness against this disease.
GV backs hair loss biotech out of UCLA with PhII set for mid-2024
Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to